智利采用PINDA方案87和92治疗急性髓系白血病的结果。 - Suppr

Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 results.

作者信息

Quintana J, Advis P, Becker A, Beresi V, Campbell M, Vinés E F, García H, Salgado C, Vargas L, Rojas J, Obando M, Neira L, Páez E, Zolezzi P

出版信息

Leukemia. 2005 Dec;19(12):2143-6. doi: 10.1038/sj.leu.2403959.

DOI:10.1038/sj.leu.2403959

PMID:16304574

Abstract

摘要

相似文献

Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 results.智利采用PINDA方案87和92治疗急性髓系白血病的结果。

Leukemia. 2005 Dec;19(12):2143-6. doi: 10.1038/sj.leu.2403959.

Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials.在两项连续的急性髓系白血病 - GATLA试验中接受治疗的儿科患者的治疗策略和长期结果。

Leukemia. 2005 Dec;19(12):2139-42. doi: 10.1038/sj.leu.2403854.

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.英国连续进行的急性髓系白血病试验中儿科患者的治疗策略及长期结果

Leukemia. 2005 Dec;19(12):2130-8. doi: 10.1038/sj.leu.2403924.

Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report.

Leukemia. 2005 Dec;19(12):2072-81. doi: 10.1038/sj.leu.2403932.

Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia.波兰在连续采用三种方案治疗儿童急性髓细胞白血病方面的二十年经验。

Leukemia. 2005 Dec;19(12):2117-24. doi: 10.1038/sj.leu.2403892.

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.在四项连续的急性髓系白血病-柏林-法兰克福-明斯特（AML-BFM）试验中接受治疗的儿科患者的治疗策略和长期结果。

Leukemia. 2005 Dec;19(12):2030-42. doi: 10.1038/sj.leu.2403920.

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group.儿童急性髓细胞白血病的治疗：剂量强化可改善预后，维持治疗无益处——法国LAME（儿童急性髓细胞白血病）协作组的多中心研究

Leukemia. 2005 Dec;19(12):2082-9. doi: 10.1038/sj.leu.2403867.

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.儿童肿瘤学组（POG）关于急性髓细胞白血病（AML）的研究：对1981年至2000年间连续进行的四项儿童AML试验的综述。

Leukemia. 2005 Dec;19(12):2101-16. doi: 10.1038/sj.leu.2403927.

Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate.以优异的缓解率为目标的儿童急性髓系白血病诱导治疗。

J Clin Oncol. 2011 Jan 20;29(3):310-5. doi: 10.1200/JCO.2010.30.6829. Epub 2010 Dec 13.

Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.1980年至2000年期间，圣裘德儿童研究医院针对儿童急性髓系白血病开展的一系列临床试验。

Leukemia. 2005 Dec;19(12):2125-9. doi: 10.1038/sj.leu.2403872.

引用本文的文献

Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage.在全球舞台上绘制儿科肿瘤临床试验协作组图谱。

JCO Glob Oncol. 2022 Feb;8:e2100266. doi: 10.1200/GO.21.00266.

Outcomes of pediatric acute myeloid leukemia treatment in Western Kenya.肯尼亚西部儿科急性髓细胞白血病的治疗结果。

Cancer Rep (Hoboken). 2022 Oct;5(10):e1576. doi: 10.1002/cnr2.1576. Epub 2021 Nov 22.

A novel upregulated LncRNA-AC026150.8 promotes chemo-resistance and predicts poor prognosis in acute myeloid leukemia.一种新的上调长链非编码RNA-AC026150.8促进急性髓系白血病的化疗耐药并预示不良预后。

Cancer Med. 2021 Dec;10(23):8614-8629. doi: 10.1002/cam4.4349. Epub 2021 Oct 19.

Overexpression of KDM4D promotes acute myeloid leukemia cell development by activating MCL-1.KDM4D的过表达通过激活MCL-1促进急性髓系白血病细胞的发育。

Am J Transl Res. 2021 Apr 15;13(4):2308-2319. eCollection 2021.

ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.ZEB1 通过与 P53 结合来调节 PTEN/PI3K/AKT 信号通路，从而在急性髓系白血病中作为癌基因发挥作用。

J Cell Mol Med. 2021 Jun;25(11):5295-5304. doi: 10.1111/jcmm.16539. Epub 2021 May 7.

Evaluation of the Pediatric Neuro-Oncology Resources Available in Chile.智利儿科神经肿瘤学可用资源评估。

JCO Glob Oncol. 2021 Mar;7:425-434. doi: 10.1200/GO.20.00430.

Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML).长链非编码 RNA HOXA-AS2 通过与 EZH2 结合并抑制急性髓系白血病 (AML) 中的 LATS2 发挥癌基因作用。

Cell Death Dis. 2020 Dec 2;11(12):1025. doi: 10.1038/s41419-020-03193-3.

E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2.E2F4 通过与 EZH2 结合抑制 MAPK 信号通路，在急性髓系白血病中作为肿瘤抑制因子发挥作用。

J Cell Mol Med. 2020 Feb;24(3):2157-2168. doi: 10.1111/jcmm.14853. Epub 2020 Jan 14.

LncRNA ANRIL regulates AML development through modulating the glucose metabolism pathway of AdipoR1/AMPK/SIRT1.长链非编码 RNA ANRIL 通过调节 AdipoR1/AMPK/SIRT1 葡萄糖代谢通路调控 AML 的发生发展。

Mol Cancer. 2018 Aug 22;17(1):127. doi: 10.1186/s12943-018-0879-9.

Survival of Mexican children with acute myeloid leukaemia who received early intensification chemotherapy and an autologous transplant.接受早期强化化疗和自体移植的墨西哥急性髓系白血病儿童的生存率。

Biomed Res Int. 2015;2015:940278. doi: 10.1155/2015/940278. Epub 2015 Mar 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 results.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献